spacer
home > pmps > summer 2007 > prescriptive drugs?
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Prescriptive Drugs?

Should you care about the patient compliance of your drug? Can you do anything to influence how and whether patients follow the prescribed regimen? According to Thomas Grinnan of MeadWestvaco, the answer to these questions is yes

The issue of non-compliance and poor adherence to drug therapy is not a new challenge to the global pharmaceutical industry, but the extent of the problem is finally being brought to light. Recent recognition of and subsequent studies on the importance of patient compliance are a welcome step in the right direction, and solutions are now coming to market. Addressing the issue of non-compliance requires a unique combination of detailed disease state and drug class information combined with innovative solutions and technology. Packaging can play a strong role in these solutions, due to its relatively low cost, direct access to patients during the regimen and its ability to contain embedded communication to remind and educate.

Given the existing challenges facing the pharmaceutical market (thin pipelines, pricing pressure and litigation, among others), potential solutions to the compliance issue should be effectively and quickly explored. The New York Times referred to non-compliance as ‘the other drug problem’. Some refer to the pharmaceutical industry’s search for new patients as the continuous filling of a bathtub with water, while noncompliance is the unplugged drain hole in the bottom.

WHO SHOULD CARE ABOUT COMPLIANCE?

Brand managers, packaging designers, packaging suppliers and even clinical researchers should all view compliance as a priority. National healthcare organisations, insurance companies and healthcare providers also need to focus on encouraging patients, as these organisations both have an impact on and benefit from patient adherence. It is clear that patient adherence benefits patients, physicians, pharmacies, payer organisations (national healthcare or insurance), employers and pharmaceutical companies. It is one of the few ‘win-win’ challenges facing nearly all healthcare stakeholders, representing a unique opportunity.

The statistics are long and compelling. Poor compliance to prescribed drug regimens accounts for 10 per cent of hospital admissions, 23 per cent of nursing home admissions and as many as 125,000 deaths each year in the US. It also accounts for €75 million in healthcare costs in Europe and $100 million in the US every year.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
5
     

There are no comments in regards to this article.

spacer
Thomas Grinnan is Director of MeadWestvaco Healthcare Packaging Europe, a leading provider of speciality packaging solutions, including pharmaceutical compliance systems and intelligent devices. He has been working in healthcare packaging for more than 16 years. Thomas spent his early career with Markowitz & McNaughton, Inc, where he focused on the life science and healthcare packaging industries. He then joined Mebane Packaging Group, joining Westvaco Corporation in 2000 as Vice President, Business Development, following Westvaco’s acquisition of Mebane. Westvaco Corp and Mead Corp merged in 2001. He holds a BA in Biology and French from the University of Virginia and an MBA from the University of North Carolina at Chapel Hill.
spacer
Thomas Grinnan
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Sustainability, plastics and Brexit: Keynote speakers set to inspire at PPMA Total Show 2019

Experts from IKEA, the British Plastics Federation and The Sunday Times to create a forum for education, knowledge-sharing and debate
More info >>

White Papers

PhlexEarchive: The Right Solution for Electronic Archiving of TMF Content

Phlexglobal Ltd

Many sponsor organizations have already recognized the value of moving from paper to electronic Trial Master Files (eTMFs). But few sponsors have taken a more holistic approach to the TMF lifecycle and looked at the entire process from study start-up through archiving of the TMF in electronic format, also known as e-archiving. The recurring value of managing, tracking, maintaining and accessing electronic files should not stop at the point of archiving. All of the challenges of managing an active paper TMF carry through to a paper archive. All of the benefits of an electronic TMF also carry through to the electronic archive. As companies look to move their compliance assets to secure, long-term storage, it is important to consider ongoing compliance requirements, security, accessibility, efficiency and costs of archiving TMF content in a digital format.
More info >>

 
Industry Events

Nordic Life Science Days 10/12 September 2019

10-12 September 2019, Malmo Sweden

Nordic Life Science Days is the largest Nordic partnering conference for the global Life Science industry. Bringing together the best talents in Life Science, offering amazing networking and partnering opportunities, providing inputs and content on the most recent trends. Nordic Life Science Days attracts leading decision makers from the Life Science sector, not only from biotech, pharma and medtech but also from finances, research, policy and regulatory authorities.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement